Abbott Laboratories

NYSE: ABT
$115.90
+$0.87 (+0.8%)
Closing Price on November 15, 2024

ABT Articles

The 24/7 Wall Street Corporate Power Rankings of the thirty-two most important companies in America are determined by earnings, analyst rankings, important corporate news, trends in each firm’s...
The 24/7 Wall Street Corporate Power Rankings of the thirty-two most important companies in America are determined by earnings, analyst rankings, important corporate news, trends in each firm’s...
The 24/7 Wall Street Corporate Power Rankings of the thirty-two most important companies in America are determined by earnings, analyst rankings, important corporate news, trends in each firm’s...
The 24/7 Wall Street Corporate Power Rankings of the thirty-two most important companies in America are determined by earnings, analyst rankings, important corporate news, trends in each firm’s...
The 24/7 Wall Street Corporate Power Rankings of the thirty-two most important companies in America are determined be earnings, analyst rankings, important corporate news, trends in each firm’s...
The 24/7 Wall Street Corporate Power Rankings of the thirty-two most important companies in America are determined be earnings, analyst rankings, important corporate news, trends in each firm’s...
We have compiled from press releases and from company announcements a company-by-company donation and effort pledge to help in the relief efforts after the disastrous earthquake in Haiti.  These are...
The 24/7 Wall Street Corporate Power Rankings of the thirty-two most important companies in America are determined be earnings, analyst rankings, important corporate news, trends in each firm’s...
It was early in October before earnings season kicked off into full thrust when we first reviewed many large or actively traded stocks which had not participated in the stock market rally of 2009. ...
Here we are going into yet another earnings season.  We saw Monday how the market has rallied significantly from the March lows and the major indexes are even up in positive territory for the 2009...
We may have had earnings season officially start with Alcoa this week, but next week will be the real week for the launch of earnings season.  We now have an index to track the top 500 companies by...
Reuters:   Solvay sold its drug unit to Abbott (ABT) foe $6.6 billion. Reuters:   Kraft (KFT) will launch a hostile bid for Cadbury. Reuters:   The World Bank said not to take the dollar’s...
Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential market....
Reuters:   Cybercrime is spreading fast on Facebook. Reuters:   GM will seek to sell most of its assets to a new company. Reuters:    Madoff got 150 years in prison. Reuters:   AIG (AIG)...
Word is out that the Dow Jones Indexes team is set to release the name of the replacement for General Motors (NYSE: GM) in the Dow Jones Industrial Average.  We have heard that the new candidate...